Female, (%) |
29 (60.4) |
22 (59.4) |
8 (72.7) |
Age, years (IQR) |
59 (38; 68) |
59 (38; 68) |
58 (52;
63) |
PENFAST, % |
|
|
|
Low risk
|
31 (64.6)
|
24 (64.9)
|
7 (63.6)
|
Moderate risk
|
11 (22.9)
|
8 (21.6)
|
3 (27.3)
|
High risk
|
5 (10.4)
|
4 (10.8)
|
1 (9)
|
Unknown
|
1 (2)
|
1 (2.7)
|
0
|
Questions from PENFAST |
|
|
|
Penicillin allergy reported
|
48 (100)
|
37 (100)
|
11 (100)
|
Five years or less since reaction
|
9 (18.8)
|
5 (13.5)
|
4 (36.3)
|
Anaphylaxis or angioedema
|
10 (20.8)
|
7 (18.9)
|
3 (27.2)
|
Severe cutaneous adverse reaction
|
7 (14.6)
|
6 (16.2)
|
1 (9)
|
Required treatment
|
30 (62.5)
|
24 (64.9)
|
6 (54.5)
|
Reaction >10 years |
35 (72.9) |
28 (75.7) |
7
(63.6) |
Patient can recall event |
31 (64.6) |
22 (59.5) |
9
(81.8) |
Family history only |
6 (12.5) |
4 (10.8) |
2 (18.2) |
Required adrenaline |
10 (20.8) |
8 (21.6) |
2 (18.2) |
Hospital admission and re-admission details |
|
|
|
Duration of admission, days (IQR) |
6 (4; 15) |
6 (4;15) |
Unknown |
Duration of admission not known |
12 (24.5) |
1 (2.6) |
11
(100) |
Number of re-admissions in following 6 months |
0 (0;2) |
0 (0;2) |
Unknown |